Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2022 Jun 17;41:204. doi: 10.1186/s13046-022-02413-2

Retraction Note: Knockdown of FOXO3a induces epithelialmesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the βcatenin/TCF4 pathway through SPRY2

Jun Li 1,2,#, Rumeng Yang 1,2,#, Yuting Dong 1,2, Manyao Chen 1,2, Yu Wang 1,, Guoping Wang 1,2,
PMCID: PMC9204885  PMID: 35715842

Retraction Note: J Exp Clin Cancer Res 38, 38 (2019)

https://doi.org/10.1186/s13046-019-1046-x

The Editor-in-Chief has retracted this article. A Correction was published in 2021 [1]. Subsequently concerns have been raised with respect to both the original figures and the figures in the Correction. The authors have not provided a satisfactory response to these concerns and so the Editor-in-Chief no longer has confidence in the data presented. All authors disagree with this retraction.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jun Li and Rumeng Yang contributed equally to this work.

Contributor Information

Yu Wang, Email: tongjisiyu@163.com.

Guoping Wang, Email: wanggp@hust.edu.cn.

References

  • 1.Li J, Yang R, Dong Y. et al. Correction to: Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2. J Exp Clin Cancer Res. 2021;40:249. 10.1186/s13046-021-02033-2. [DOI] [PMC free article] [PubMed]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES